Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 68.65% | 77.92% | 125.71% | 73.60% | 16.33% |
Total Depreciation and Amortization | -48.96% | -39.14% | -66.97% | 13.98% | 168.78% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 89.07% | -40.16% | -22.00% | -61.82% | -2,260.52% |
Change in Net Operating Assets | 44.22% | 230.72% | -76.67% | -75.04% | 54.01% |
Cash from Operations | 66.74% | 366.15% | -15.83% | -67.18% | 11.55% |
Capital Expenditure | -219.32% | -64.20% | -12.15% | -77.29% | 106.81% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -101.35% | 41.55% | -91.99% | -7.69% | 154.78% |
Cash from Investing | -101.72% | 40.28% | -92.55% | -9.78% | 561.05% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 65,800.00% | 609.68% | -91.48% | -- | -98.98% |
Repurchase of Common Stock | -722.25% | -145.04% | -671.70% | -12.64% | -1,869.05% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -643.46% | -137.70% | -2,073.47% | -57.40% | -101.00% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 46.70% | 180.81% | -61.08% | -63.53% | 10.88% |